Global Advanced Molecular Nuclear Imaging Market, By Product (SPECT Systems, Hybrid PET Systems Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, Others), End-User (Hospitals, Imaging Centers, Academic and Research Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Advanced Molecular Nuclear Imaging Market
Advanced molecular nuclear imaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.61% in the above-mentioned forecast period. Rise in the prevalence and incidence of cancer & cardiovascular diseases drives the advanced molecular nuclear imaging market swiftly.
Advanced molecular nuclear imaging procedures are defined as the type of non-invasive and are usually painless medical tests that help doctors to diagnose and examine medical conditions. These imaging tests use radiopharmaceutical or radiotracer materials.
Rising investment for the innovation of diagnostic imaging centers as well as development of new radiotracers is the vital factor escalating the market growth, also rise in the prevalence and incidence of cancer & cardiovascular diseases and high accuracy of nuclear imaging are the major factors driving the advanced molecular nuclear imaging market. Moreover, rise in the research and development activities in the market and rise in the demand from emerging economies will further create opportunities for advanced molecular nuclear imaging market in the forecasted period of 2021-2028.
However, high cost of device and rise in the stringent regulations are the major factors among others acting act as restraints, and will further challenge the growth of advanced molecular nuclear imaging market in the forecast period mentioned above.
This advanced molecular nuclear imaging market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research advanced molecular nuclear imaging market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Advanced Molecular Nuclear Imaging Market Scope and Market Size
Advanced molecular nuclear imaging market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product, the advanced molecular nuclear imaging market is segmented into SPECT systems and hybrid pet systems planar scintigraphy.
- Based on application, the advanced molecular nuclear imaging market is segmented into oncology, cardiology, neurology and others.
- Advanced molecular nuclear imaging market is also segmented on the basis of end-user into hospitals, imaging centers, academic and research centers and others.
Advanced Molecular Nuclear Imaging Market Country Level Analysis
Advanced molecular nuclear imaging market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the advanced molecular nuclear imaging market due to rise in the prevalence and incidence of cancer & cardiovascular diseases and high accuracy of nuclear imaging in this region.
The country section of the advanced molecular nuclear imaging market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
Advanced molecular nuclear imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for advanced molecular nuclear imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the advanced molecular nuclear imaging market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Advanced Molecular Nuclear Imaging Market Share Analysis
Advanced molecular nuclear imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related life to advanced molecular nuclear imaging market.
The major players covered in the advanced molecular nuclear imaging market report are Siemens Healthcare Private Limited, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Neusoft Corporation, Mediso Ltd, Digirad Corporation, CMR Naviscan, SurgicEye GmbH, DDD-Diagnostic A/S, Nordion (Canada) Inc, Cardinal Health, Bracco Diagnostic Inc., Lantheus Medical Imaging, Inc, Jubilant Pharma. LLC, IRE - IRE ELiT - BE, NTP, Novartis AG, Cambridge Isotope Laboratories, Inc and FUJIFILM Holdings Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-